WebApr 16, 2024 · View this $249000 2 bed, 2.0 bath, 734 sqft single family home located at 1540 S 17th Ave SW #309 built in 2001 on Zillow. MLS # A2039007. WebAug 3, 2015 · To evaluate rheumatologists’ adherence to a low Disease Activity Score (DAS)–steered treat-to-target (T2T) strategy in treatment of patients with rheumatoid arthritis (RA) and to assess associated conditions. Methods Data of the BeSt study were used, a multicenter T2T strategy trial with 10-year followup.
ASHG 2024 Scientific Program - ASHG
WebAn article in the American Heart Association’s journal Circulation: Cardiovascular Quality and Outcomes has the details: The Effect of an EDTA-based Chelation Regimen on Patients … WebEvidence for the benefit of a T2T approach has been published in psoriatic arthritis, a form of spondyloarthritis. Summary: However, data from a prospective randomized study proving the efficacy of a T2T strategy compared to routine care are still lacking. lowvy
Treat to Target, Remission and Low Disease Activity in the Treatment of
PHILADELPHIA—Treat to target (T2T) is a common phrase in rheumatology these days—and a welcome one. 1 Many of us are familiar with what T2T means in rheumatoid arthritis (RA), but we may be less sure of its meaning in axial spondyloarthritis (axSpA). See more ASAS-EULAR recommends targeting low disease activity or remission, as defined by the ASDAS-CRP—and as used in TICOSpA—to T2T in axSpA.2“This is fairly easy to implement in clinical practice, but most of us don’t have … See more Several contextual factors help explain why some patients respond better to treatment than others, and some have persistently higher disease activity scores. For example, studies show that depression affects response to … See more Dr. Ogdie concluded her talk with thoughts on how to develop a better T2T strategy, posing the question, “Maybe it’s not the target, but our general approach to axSpA that’s the problem. I think we should move to a whole-patient … See more WebAug 10, 2024 · Aug 10, 2024 Hayden E. Klein According to the review, the most important novel developments were related to the repositioning of old drugs in the context of treat-to-target (T2T) therapy and new... WebPhysician-reported T2T use and barriers to T2T implementation were also collected, including physician-reported treatment goals, advanced therapy use and barriers to advanced therapy initiation, reasons for advanced therapy choice and satisfaction with treatment outcomes. jazz chisholm mlb.com